# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TD Cowen analyst Gary Taylor maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $371 to $360.
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $356 to $...
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $322 ...
Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target fro...
Strong earnings reports from Alphabet Inc. (NASDAQ:GOOGL) and Microsoft Corp. (NASDAQ:MSFT) have restored positive sentiment in...
HCA Healthcare's first-quarter results, surpassing revenue and EPS expectations. CEO Sam Hazen emphasizes sustained momentu...
-Conf. Call